ConductScience.org, home

Paper · 20056790

High-throughput cell transplantation establishes that tumor-initiating cells are abundant in zebrafish T-cell acute lymphoblastic leukemia.

Smith AC and 12 others. Blood, 2010. Cited by 103 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. High-throughput cell transplantation establishes that tumor-initiating cells are abundant in zebrafish T-cell acute lymphoblastic leukemia. Papers, record 20056790. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20056790

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
High-throughput cell transplantation establishes that tumor-initiating cells are abundant in zebrafish T-cell acute lymphoblastic leukemia.
PubMed
Journal
Blood
PubMed
Year
2010
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
103
iCite
Relative citation ratio, by iCite
2.06
iCite
Revised in PubMed
2021-10-20
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Smith ACAlexandra C H
2Raimondi ARAubrey R
3Salthouse CDChris D
4Ignatius MSMyron S
5Blackburn JSJessica S
6Mizgirev IVIgor V
7Storer NYNarie Y
8de Jong JLJill L O
9Chen ATAye T
10Zhou YYi

1 to 10 of 13Source PubMed

See all 13 authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Disease Models, AnimalMajor topic
Neoplasm TransplantationMajor topic
Neoplastic Stem CellsMajor topic
Precursor T-Cell Lymphoblastic Leukemia-LymphomaMajor topic
ZebrafishMajor topic
Animals
Animals, Genetically Modified
Cell Separation
Flow Cytometry
Image Processing, Computer-Assisted
Microscopy, Fluorescence

Source PubMed

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
5 R01 CA103846-04NCI NIH HHSUnited StatesR01CA103846PubMed and NIHNIH RePORTER
T32 GM007753NIGMS NIH HHSUnited StatesT32GM007753PubMed and NIHNIH RePORTER
R01 CA103846NCI NIH HHSUnited StatesR01CA103846PubMed and NIHNIH RePORTER
3 K01 AR055619-03S1NIAMS NIH HHSUnited StatesK01AR055619PubMed and NIHNIH RePORTER
K01 AR055619-01A1NIAMS NIH HHSUnited StatesK01AR055619PubMed and NIHNIH RePORTER
K01 AR055619NIAMS NIH HHSUnited StatesK01AR055619PubMed and NIHNIH RePORTER

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References28

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115,472,075Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia.Science2004https://conductscience.org/library/papers/15472075PubMed
217,114,293NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth.Proc Natl Acad Sci U S A2006https://conductscience.org/library/papers/17114293PubMed
319,516,274Heritable T-cell malignancy models established in a zebrafish phenotypic screen.Leukemia2009https://conductscience.org/library/papers/19516274PubMed
417,510,286Effects of RAS on the genesis of embryonal rhabdomyosarcoma.Genes Dev2007https://conductscience.org/library/papers/17510286PubMed
514,582,078Gene expression profiling in T-cell acute lymphoblastic leukemia.Semin Hematol2003https://conductscience.org/library/papers/14582078PubMed
618,345,029Co-injection strategies to modify radiation sensitivity and tumor initiation in transgenic Zebrafish.Oncogene2008https://conductscience.org/library/papers/18345029PubMed
717,641,192Tumor growth need not be driven by rare cancer stem cells.Science2007https://conductscience.org/library/papers/17641192PubMed
816,540,662Transplantable tumor lines generated in clonal zebrafish.Cancer Res2006https://conductscience.org/library/papers/16540662PubMed
915,142,873Effects of lethal irradiation in zebrafish and rescue by hematopoietic cell transplantation.Blood2004https://conductscience.org/library/papers/15142873PubMed
1018,372,910Catch of the day: zebrafish as a human cancer model.Oncogene2008https://conductscience.org/library/papers/18372910PubMed

Cited by81

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 103 citations.

PMIDTitleJournalYearIn PapersSource
42,879,028Using Zebrafish Larvae as a Xenotransplantation Model to Study Ewing Sarcoma.Methods Mol Biol2027https://conductscience.org/library/papers/42879028PubMed
42,802,717Zebrafish against cancer: towards clinical relevance.Dis Model Mech2026https://conductscience.org/library/papers/42802717PubMed
42,699,572MAPK-driven MYC/p21 axis controls senescence bypass and BCL-XL dependence in vincristine-resistant rhabdomyosarcoma.iScience2026https://conductscience.org/library/papers/42699572PubMed
39,216,481A conserved transcription factor regulatory program promotes tendon fate.Dev Cell2024https://conductscience.org/library/papers/39216481PubMed
39,052,000A syngeneic spontaneous zebrafish model of tp53-deficient, EGFRvIII, and PI3KCAH1047R-driven glioblastoma reveals inhibitory roles for inflammation during tumor initiation and relapse in vivo.Elife2024https://conductscience.org/library/papers/39052000PubMed
38,656,392Dynamic Changes in Lymphocyte Populations Establish Zebrafish as a Thymic Involution Model.J Immunol2024https://conductscience.org/library/papers/38656392PubMed
38,104,416Zebrafish drug screening identifies Erlotinib as an inhibitor of Wnt/β-catenin signaling and self-renewal in T-cell acute lymphoblastic leukemia.Biomed Pharmacother2024https://conductscience.org/library/papers/38104416PubMed
37,188,201Tumor heterogeneity: preclinical models, emerging technologies, and future applications.Front Oncol2023https://conductscience.org/library/papers/37188201PubMed
37,179,373Immune gene variation associated with chromosome-scale differences among individual zebrafish genomes.Sci Rep2023https://conductscience.org/library/papers/37179373PubMed
36,428,753Targeting Leukemia-Initiating Cells and Leukemic Niches: The Next Therapy Station for T-Cell Acute Lymphoblastic Leukemia?Cancers (Basel)2022https://conductscience.org/library/papers/36428753PubMed

1 to 10 of 81

See all 81 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20056790

GET https://conductscience.org/api/papers/v1/20056790/references?page=2